Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Sanofi
Description mAb targeting CC chemokine receptor 5 (CCR5; CD195)
Molecular Target CC chemokine receptor 5 (CCR5) (CD195)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationLupus
Indication DetailsTreat systemic lupus erythematosus (SLE)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today